NASDAQ:AVGR Avinger (AVGR) Stock Price, News & Analysis → A new way to collect income from stocks (From DTI) (Ad) Free AVGR Stock Alerts $3.93 +0.23 (+6.22%) (As of 02:29 PM ET) Add Compare Share Share Today's Range$3.72▼$3.9550-Day Range$2.82▼$5.3452-Week Range$2.50▼$18.00Volume12,428 shsAverage Volume45,830 shsMarket Capitalization$6.25 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Avinger alerts: Email Address Avinger MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside27.2% Upside$5.00 Price TargetShort InterestHealthy2.86% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.33Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.08) to ($1.35) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.62 out of 5 stars 3.5 Analyst's Opinion Consensus RatingAvinger has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageAvinger has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.86% of the float of Avinger has been sold short.Short Interest Ratio / Days to CoverAvinger has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Avinger has recently decreased by 16.90%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAvinger does not currently pay a dividend.Dividend GrowthAvinger does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AVGR. Previous Next 1.9 News and Social Media Coverage News SentimentAvinger has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Avinger this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for AVGR on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Avinger to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Avinger insiders have not sold or bought any company stock.Percentage Held by Insiders11.40% of the stock of Avinger is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 18.30% of the stock of Avinger is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Avinger are expected to grow in the coming year, from ($2.08) to ($1.35) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avinger is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avinger is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Insider FinancialThousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.Simply tap here now to subscribe and start getting "Insider Financial Advantage" About Avinger Stock (NASDAQ:AVGR)Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.Read More AVGR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AVGR Stock News HeadlinesApril 24, 2024 | americanbankingnews.comAvinger (NASDAQ:AVGR) Stock Price Crosses Above Fifty Day Moving Average of $3.41April 24, 2024 | americanbankingnews.comStockNews.com Begins Coverage on Avinger (NASDAQ:AVGR)April 25, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.April 16, 2024 | americanbankingnews.comAvinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.comApril 3, 2024 | msn.comAvinger files to sell 2.05M shares for holdersMarch 22, 2024 | seekingalpha.comAvinger, Inc. (AVGR) Q4 2023 Earnings Call TranscriptMarch 21, 2024 | finance.yahoo.comAvinger, Inc. (NASDAQ:AVGR) Q4 2023 Earnings Call TranscriptMarch 20, 2024 | investorplace.comAVGR Stock Earnings: Avinger Misses Revenue for Q4 2023April 25, 2024 | DTI (Ad)How a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…March 12, 2024 | finance.yahoo.comAvinger to Announce Full Year 2023 Results on March 20, 2024March 11, 2024 | seekingalpha.comWeek In Review: EurekaBio Raises $40M To Support Lentiviral Vector PlatformMarch 7, 2024 | msn.comAvinger enters partnership with Zylox-Tonbridge, to get $15 million of equity fundingMarch 7, 2024 | prnewswire.comZylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular InterventionsMarch 6, 2024 | finanznachrichten.deAvinger, Inc.: Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-TonbridgeMarch 6, 2024 | stockhouse.comImportant Notice to Avinger Investors and Aegis Capital Customers: Please Contact the Law Firm of KlaymanToskesMarch 1, 2024 | yahoo.comUT Tyler to host free health screenings in Avinger on SaturdayFebruary 29, 2024 | edition.cnn.comAvinger, Inc.February 21, 2024 | benzinga.comWhy International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionDecember 14, 2023 | health.usnews.comShanetia S. AvingerDecember 1, 2023 | benzinga.comAvinger Stock (NASDAQ:AVGR) Dividends: History, Yield and DatesOctober 27, 2023 | finance.yahoo.comAvinger, Inc. (NASDAQ:AVGR) Q3 2023 Earnings Call TranscriptOctober 26, 2023 | finanznachrichten.deAvinger, Inc.: Avinger Reports Third Quarter 2023 ResultsOctober 26, 2023 | finance.yahoo.comAvinger Reports Third Quarter 2023 ResultsOctober 26, 2023 | finance.yahoo.comAvinger (AVGR) Reports Q3 Loss, Lags Revenue EstimatesOctober 25, 2023 | benzinga.comAvinger Earnings PreviewOctober 19, 2023 | finance.yahoo.comAvinger to Announce Third Quarter 2023 Results on October 26September 27, 2023 | finanznachrichten.deAvinger, Inc.: Avinger Raises $5.3 Million via At-The-Market FacilitySee More Headlines Receive AVGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/20/2024Today4/25/2024Next Earnings (Estimated)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:AVGR CUSIPN/A CIK1506928 Webwww.avinger.com Phone(650) 241-7900Fax800-229-2696Employees68Year FoundedN/APrice Target and Rating Average Stock Price Target$5.00 High Stock Price Target$5.00 Low Stock Price Target$5.00 Potential Upside/Downside+27.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($26.3406) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,320,000.00 Net Margins-239.41% Pretax Margin-239.41% Return on EquityN/A Return on Assets-106.16% Debt Debt-to-Equity RatioN/A Current Ratio0.63 Quick Ratio0.36 Sales & Book Value Annual Sales$7.65 million Price / Sales0.82 Cash FlowN/A Price / Cash FlowN/A Book Value($4.53) per share Price / Book-0.87Miscellaneous Outstanding Shares1,590,000Free Float1,405,000Market Cap$6.25 million OptionableNot Optionable Beta1.26 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Jeffrey M. Soinski (Age 62)President, CEO & Director Comp: $616.79kMr. Nabeel P. Subainati (Age 40)VP of Finance, Principal Financial Officer & Accounting Officer Comp: $347.58kMr. Himanshu N. Patel (Age 64)Chief Technology Officer Comp: $430.08kMr. Keith SchaeferChief Operating OfficerMr. Philip R. Preuss (Age 46)Chief Marketing Officer & VP of Business Operations Mr. Corey GibbsVice President of SalesDr. Jaafer Golzar FACCM.D., Chief Medical OfficerMore ExecutivesKey CompetitorsVenus ConceptNASDAQ:VEROAcutus MedicalNASDAQ:AFIBPlus TherapeuticsNASDAQ:PSTVSharps TechnologyNASDAQ:STSSAssureNASDAQ:IONMView All Competitors AVGR Stock Analysis - Frequently Asked Questions Should I buy or sell Avinger stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AVGR shares. View AVGR analyst ratings or view top-rated stocks. What is Avinger's stock price target for 2024? 1 analysts have issued 12-month price targets for Avinger's stock. Their AVGR share price targets range from $5.00 to $5.00. On average, they predict the company's stock price to reach $5.00 in the next year. This suggests a possible upside of 27.2% from the stock's current price. View analysts price targets for AVGR or view top-rated stocks among Wall Street analysts. How have AVGR shares performed in 2024? Avinger's stock was trading at $2.71 on January 1st, 2024. Since then, AVGR shares have increased by 45.0% and is now trading at $3.93. View the best growth stocks for 2024 here. Are investors shorting Avinger? Avinger saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 41,800 shares, a drop of 16.9% from the March 31st total of 50,300 shares. Based on an average daily trading volume, of 53,000 shares, the short-interest ratio is currently 0.8 days. Currently, 2.9% of the company's shares are short sold. View Avinger's Short Interest. When is Avinger's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our AVGR earnings forecast. How were Avinger's earnings last quarter? Avinger, Inc. (NASDAQ:AVGR) issued its quarterly earnings data on Wednesday, March, 20th. The medical device company reported ($3.93) earnings per share for the quarter, missing the consensus estimate of $0.64 by $4.57. The medical device company earned $1.91 million during the quarter, compared to analysts' expectations of $2.52 million. When did Avinger's stock split? Shares of Avinger reverse split on the morning of Wednesday, September 13th 2023. The 1-15 reverse split was announced on Wednesday, September 13th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. What other stocks do shareholders of Avinger own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avinger investors own include Bionano Genomics (BNGO), Novan (NOVN), Titan Pharmaceuticals (TTNP), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN), Organigram (OGI), Onconova Therapeutics (ONTX), ADMA Biologics (ADMA), Aeterna Zentaris (AEZS) and Actinium Pharmaceuticals (ATNM). When did Avinger IPO? Avinger (AVGR) raised $60 million in an initial public offering (IPO) on Friday, January 30th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers. How do I buy shares of Avinger? Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:AVGR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThese AI trades triggered this morning (545% return)Prosper Trading AcademyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldYour Money is Not SafeAmerican Alternativetop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe World's First "$20 Trillion Drug?"Behind the MarketsThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
